New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:06 EDTTMHTeam Health downgraded to Buy from Conviction Buy at Goldman
Goldman removed Team Health from the Conviction Buy List based on valuation and higher Street estimates. Shares remain Buy rated with an increased price target of $59 from $56.
News For TMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2016
07:46 EDTTMHTeam Health price target lowered to $58 from $75 at Canaccord
Canaccord lowered its price target on Team Health to $58 from $75 to reflect margins estimates in line with last year's guidance, the perception of perceived integrations risk with IPC Medical and tougher comps. Canaccord maintained its Buy rating on Team Health shares.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use